CLINICAL_TRIALS
trial_result
· 2009-07-10
Clinical Trial Update: Dose Confirmation Efficacy Study (V260-007) [Phase 3]
Summary
Phase 3 dose-confirmation efficacy study (V260-007) for Merck's rotavirus vaccine completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Infections | Phase 3 | Status: COMPLETED | Results posted: 2009-07-10